April 9, 2009 - Researchers say a larger trial is needed to effectively test a novel stent designed to speed arterial healing in heart attack patients by attracting the body’s own circulating stem cells to create a protective layer over the implanted device.

April 8, 2009 - NewYork-Presbyterian Hospital’s new electronic personal health record, myNYP.org, enables patients to access their medical information wherever and whenever they need it.

April 8, 2009 - The CUPID clinical trial demonstrated acceptable safety and produced quantitative evidence of biological activity across a number of parameters important for assessing heart failure, Celladon Corp. announced today.

April 5, 2009 - InSite One Inc. announced at HIMSS 2009 it will re-sign a three-year contact with InSight Health Corp. for its imaging centers’ enterprise storage with a cohesive service level agreement as the exclusive archive provider, providing InSite One’s InDex DICOM standards-based storage and content management services.

April 7, 2009 - The American Heart Association/American Stroke Association is providing recommendations for the use of minimally invasive procedures to treat brain blood vessel diseases.

April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (formerly marketed as VASOVIST, gadofosveset trisodium, by Bayer Schering Pharma) from EPIX Pharmaceuticals.

April 6, 2009 - TeraRecon Inc. recently announced the election of a new board of directors at its annual meeting of the shareholders held last week. The elected directors are TeraRecon founder Motoaki Saito, M.D., Ph.D., Robert James Taylor, Ph.D., Fumio Urano, Shigeyuki Watanabe and Matthew James Ostrander. Biographies for each director can be found on the company’s website.